Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity modulated pelvic radiation therapy

被引:2
|
作者
Mell, LK
Kochanski, J
Roeske, J
Rash, C
Kubisch, R
Mundt, A
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Illinois, Chicago, IL 60680 USA
关键词
D O I
10.1016/j.ijrobp.2005.07.166
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
160
引用
收藏
页码:S96 / S97
页数:2
相关论文
共 50 条
  • [1] Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy
    Mell, Loren K.
    Kochanski, Joel D.
    Roeske, John C.
    Haslam, Josh J.
    Mehta, Neil
    Yamada, S. Diane
    Hurteau, Jean A.
    Collins, Yvonne C.
    Lengyel, Ernst
    Mundt, Arno J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (05): : 1356 - 1365
  • [2] Dosimetric Predictors of Acute Hematologic Toxicity Due to Intensity-Modulated Pelvic Radiation Therapy with Concurrent Chemotherapy for Chinese Rectal and Cervical Cancer Patients
    Yang, Y.
    Li, W.
    Qian, J.
    Zhang, J.
    Shen, Y.
    Tian, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E24 - E24
  • [3] Dosimetric predictors of acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity modulated radiation therapy (IMRT)
    Mell, L. K.
    Salama, J. K.
    Roeske, J. C.
    Devisetty, K.
    Jani, A. B.
    Mundt, A. J.
    Chmura, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S277 - S278
  • [4] Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients treated with concurrent chemotherapy and intensity modulated pelvic radiotherapy
    Wan, XiangBo
    Cheng, Yikan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Dosimetric predictors of acute hematologic toxicity due to intensity-modulated pelvic radiotherapy with concurrent chemotherapy for pelvic cancer patients
    Yang, Yongqiang
    Li, Wenjing
    Qian, Jianjun
    Zhang, Junjun
    Shen, Yuntian
    Tian, Ye
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 515 - 523
  • [6] Can Dosimetric Parameters Predict Acute Hematologic Toxicity in Rectal Cancer Patients Treated With Intensity Modulated Pelvic Radiation Therapy?
    Wan, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S206 - S206
  • [7] Dosimetric Parameters of Acute Hematologic Toxicity in Cervical Cancer Patients Treated With Concurrent Cisplatin and Pelvic Radiation Therapy: Turkish Oncology Group Gynecological Tumor Subgroup Study
    Erpolat, P.
    Alco, G.
    Igdem, S.
    Dagoglu, I. Aslay N.
    Demirci, Z. Ozsaran S.
    Keven, Y. Guney E.
    Kilic, M. Akmansu D.
    Bayman, D. Etiz E.
    Mandel, N. Molinas
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S441 - S441
  • [8] Outcomes For Cervical Cancer Patients Treated With Extended Field Intensity Modulated Radiation Therapy And Concurrent Cisplatin
    Jensen, L.
    Hasselle, M. D.
    Rose, B. S.
    Nath, S. K.
    Hasan, Y.
    Yashar, C. M.
    Mundt, A. J.
    Mell, L. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S452 - S453
  • [9] Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer
    Franco, P.
    Ragona, R.
    Arcadipane, F.
    Mistrangelo, M.
    Cassoni, P.
    Rondi, N.
    Morino, M.
    Racca, P.
    Ricardi, U.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 67 - 75
  • [10] Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer
    P. Franco
    R. Ragona
    F. Arcadipane
    M. Mistrangelo
    P. Cassoni
    N. Rondi
    M. Morino
    P. Racca
    U. Ricardi
    Clinical and Translational Oncology, 2017, 19 : 67 - 75